Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance

Abstract

Cbl-associated protein (Cap) is a member of a phosphatidylinositol 3-kinase–independent pathway for insulin-stimulated translocation of the glucose transporter GLUT4. Despite this positive role of Cap in glucose uptake, here we show that deletion of the gene encoding Cap (official gene name: Sorbs1) protects against high-fat diet (HFD)–induced insulin resistance in mice while also having an opposite, insulin-sensitizing effect, accompanied by reduced tissue markers of inflammation. Given the emerging role of chronic inflammation in insulin resistance and the macrophage in initiating this inflammatory process, we considered that Sorbs1 deletion from macrophages may have resulted in the observed protection from HFD-induced insulin resistance. Using bone marrow transplantation to generate functional Sorbs1-null macrophages, we show that the insulin-sensitive phenotype can be transferred to wild-type mice by transplantation of Sorbs1-null bone marrow. These studies show that macrophages are an important cell type in the induction of insulin resistance and that Cap has a modulatory role in this function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Sorbs1 knockout strategy.
Figure 2: In vivo glucose homeostasis and insulin sensitivity.
Figure 3: Inflammatory changes after HFD.
Figure 4: Protection from insulin resistance is conferred by Sorbs1−/− macrophages.
Figure 5: Altered monocyte/macrophage function after deletion of Sorbs1.

Similar content being viewed by others

References

  1. Baumann, C.A. et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407, 202–207 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. Kanzaki, M. & Pessin, J.E. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J. Biol. Chem. 276, 42436–42444 (2001).

    Article  CAS  PubMed  Google Scholar 

  3. Alcazar, O., Ho, R., Fujii, N. & Goodyear, L. cDNA cloning and functional characterization of a novel splice variant of c-Cbl-associated protein from mouse skeletal muscle. Biochem. Biophys. Res. Commun. 317, 285–293 (2004).

    Article  CAS  PubMed  Google Scholar 

  4. Liu, J., Kimura, A., Baumann, C.A. & Saltiel, A.R. APS Facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3–L1 adipocytes. Mol. Cell. Biol. 22, 3599–3609 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. JeBailey, L. et al. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol. Endocrinol. 18, 359–372 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. Tong, P. et al. Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles. J. Clin. Invest. 108, 371–381 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Patki, V. et al. Insulin action on GLUT4 traffic visualized in single 3T3–L1 adipocytes by using ultra-fast microscopy. Mol. Biol. Cell 12, 129–141 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kimura, A., Baumann, C.A., Chiang, S-H. & Saltiel, A.R. The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. Proc. Natl. Acad. Sci. USA 98, 9098–9103 (2001).

    Article  CAS  PubMed  Google Scholar 

  9. Liu, J., DeYoung, S.M., Hwang, J.B., O'Leary, E.E. & Saltiel, A.R. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J. Biol. Chem. 278, 36754–36762 (2003).

    Article  CAS  PubMed  Google Scholar 

  10. Mitra, P., Zheng, X. & Czech, M.P. RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. J. Biol. Chem. 279, 37431–37435 (2004).

    Article  CAS  PubMed  Google Scholar 

  11. Ahn, M-Y., Katsanakis, K.D., Bheda, F. & Pillay, T.S. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J. Biol. Chem. 279, 21526–21532 (2004).

    Article  CAS  PubMed  Google Scholar 

  12. Wellen, K.E. & Hotamisligil, G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111–1119 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Weisberg, S.P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Takahashi, K. et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278, 46654–46660 (2003).

    Article  CAS  PubMed  Google Scholar 

  15. Wang, Y., Yeung, Y. & Stanley, E. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 72, 119–134 (1999).

    Article  CAS  PubMed  Google Scholar 

  16. Caveggion, E. et al. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J. Cell. Physiol. 195, 276–289 (2003).

    Article  CAS  PubMed  Google Scholar 

  17. Lee, P.S.W. et al. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18, 3616–3628 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Erdreich-Epstein, A. et al. Cbl functions downstream of Src kinases in Fcγ RI signaling in primary human macrophages. J. Leukoc. Biol. 65, 523–534 (1999).

    Article  CAS  PubMed  Google Scholar 

  19. Meng, F. & Lowell, C.A. A β1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J. 17, 4391–4403 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med. 11, 183–190 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Molero, J.C. et al. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J. Clin. Invest. 114, 1326–1333 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Minami, A. et al. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52, 2657–2665 (2003).

    Article  CAS  PubMed  Google Scholar 

  24. Molero, J.C. et al. Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes 55, 708–715 (2006).

    Article  CAS  PubMed  Google Scholar 

  25. Hevener, A.L. et al. Muscle-specific Pparg deletion causes insulin resistance. Nat. Med. 9, 1491–1497 (2003).

    Article  CAS  PubMed  Google Scholar 

  26. Gu, H., Zou, Y.R. & Rajewsky, K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre–loxP-mediated gene targeting. Cell 73, 1155–1164 (1993).

    Article  CAS  PubMed  Google Scholar 

  27. Chen, A. et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 13, 1311–1320 (2005).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank K. Chien for donation of the Sorbs1−/− mouse, T. Tran for performing the metabolic cage studies and J. Juliano for the hepatic triglyceride content measurements. This study was funded in part by the University of California Discovery Program Project (bio03-10383, BioStar) with matching funds from Pfizer Incorporated. This work was also supported by the National Institutes of Health (grants DK 33651 to J.M.O. and DK 60591 to A.R.S.). J.M.O. is a consultant for Pfizer Incorporated.

Author information

Authors and Affiliations

Authors

Contributions

L.A.L. completed the GTT, ITT, clamp studies, histological analyses, peritoneal macrophage isolations, bone marrow transplantations, immunoblotting, data analysis and manuscript preparation as a member of J.M.O.'s laboratory. S.E.H. carried out immunoblotting, assisted with peritoneal macrophage isolations and performed the LPS stimulation experiments. J.G.N. assisted with bone marrow transplantations and clamp studies. C.d.L. performed real-time PCR, GTTs, ITTs and assisted with clamp studies. M.P. generated the Sorbs1−/− mouse strain while in K. Chien's laboratory. C.N.L. and S.-H.C., members of A.R.S.'s laboratory, performed studies examining Sorbs1 function in RAW macrophages and isolated adipocytes. S.-H.C. also provided immunoblots showing Cap protein deletion. M.S. performed MRI scanning and analysis.

Corresponding author

Correspondence to Jerrold M Olefsky.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

No differences in metabolism or body composition between Cap(+/+) and Cap(−/−). (PDF 191 kb)

Supplementary Table 1

Animal characteristics, insulin sensitivity and macrophage infiltration into adipose tissue in HFD fed mice following reverse BMT experiments. (PDF 51 kb)

Supplementary Methods (PDF 72 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lesniewski, L., Hosch, S., Neels, J. et al. Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance. Nat Med 13, 455–462 (2007). https://doi.org/10.1038/nm1550

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1550

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing